HOME > TOP STORIES
TOP STORIES
-
BUSINESS April-September Sales Drop 21.5% for Major Long-Listed Products
December 8, 2014
-
BUSINESS Daiichi Sankyo to Harness Ties with Cardiologists in Lixiana Promotion
December 8, 2014
-
BUSINESS Nippon Chemiphar to Set Up Plant in Vietnam, Operation Launch Slated in 2018
December 5, 2014
-
REGULATORY ICH Makes Progress Toward Greater Inclusivity, Agrees to Establish Assembly at November Meeting in Lisbon
December 4, 2014
-
REGULATORY Pharma Industry Girding for Post-Election Lobbying on R&D Tax Credit
December 3, 2014
-
BUSINESS Otsuka to Buy US Firm Avanir Pharmaceuticals to Fully Enter Neurology Market
December 3, 2014
-
BUSINESS Takeda’s Proteasome Inhibitor Ixazomib Granted Breakthrough Therapy Designation by US FDA
December 3, 2014
-
BUSINESS A-zas Looks to Offer E-Detailing App, Big-Data Analyses to More Firms
December 2, 2014
-
REGULATORY PAFSC’s Second Committee Backs Approval of Novartis’s Secukinumab
December 1, 2014
-
BUSINESS EPS Gives 400 Workers CDISC Training to Set Itself Apart from Rival CROs
November 28, 2014
-
INTERVIEW Gilead Starting from Scratch to Build Solo Sales Regime: Japan Pres.
November 28, 2014
-
ACADEMIA Avigan’s Efficacy in Ebola “Unknown” with No Corroborative Data: NIID Official
November 27, 2014
-
BUSINESS Kaken Banking on Clenafin to Boost Dermatology Biz
November 27, 2014
-
REGULATORY Debates on Yearly NHI Price Cuts Put on Hold as Attention Turns to Election
November 26, 2014
-
REGULATORY PAFSC First Committee Backs Approval of Takeda’s Vonoprazan
November 25, 2014
-
ORGANIZATION JPMA President Opposes Annual NHI Price Revision
November 21, 2014
-
REGULATORY Chuikyo OKs NHI Price Listing of 14 APIs/15 Products
November 20, 2014
-
REGULATORY 3 Straight Years of NHI Price Cuts Loom as Abe Delays Sales Tax Hike, Eyes Now Turned to 2019 and Beyond
November 19, 2014
-
REGULATORY Health Ministry Drug Evaluation Head Calls for Mulling Necessity of PI Studies for Japanese Patients
November 18, 2014
-
REGULATORY PMDA to Accept All Requests for Generic Drug Face-to-Face Consultations
November 17, 2014
ページ
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
